CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Engineering, Contract and Testing Revenue	$ 340,604	$ 314,494
Operating Costs and Expenses
Amortization of patents and proprietary technology	49,713	82,934
Cost of revenue	41,381	23,055
Administrative and marketing expense	735,269	878,584
Research and development expense	319,763	318,445
Total Operating Costs and Expenses	1,146,126	1,303,018
Loss from operations	(805,522)	(988,524)
Other Income (Expense)
Interest expense	(332,616)	(1,068,389)
Interest income	47	47
Gain (loss) on extinguishment of debt	115,183	(915)
Loss on change in fair value of derivative liabilities	(60,734)	(35,403)
Net Other Income (Expense)	(278,120)	(1,104,660)
Net Loss	$ (1,083,642)	$ (2,093,184)
Basic and Diluted Loss Per Common Share	$ (0.01)	$ (0.03)
Basic and Diluted Weighted-Average Common Shares Outstanding	93,503,090	72,404,678